Raia Drogasil SA (RADLY)
4.99
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Raia Drogasil Profit Margin (Quarterly): 2.06% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 2.06% |
December 31, 2023 | 2.92% |
September 30, 2023 | 3.04% |
June 30, 2023 | 4.01% |
March 31, 2023 | 2.42% |
December 31, 2022 | 3.64% |
September 30, 2022 | 2.88% |
June 30, 2022 | 4.94% |
March 31, 2022 | 2.14% |
December 31, 2021 | 2.63% |
September 30, 2021 | 2.51% |
June 30, 2021 | 4.31% |
March 31, 2021 | 3.10% |
December 31, 2020 | 2.91% |
September 30, 2020 | 3.04% |
June 30, 2020 | 1.00% |
March 31, 2020 | 2.49% |
December 31, 2019 | 1.80% |
September 30, 2019 | 9.98% |
June 30, 2019 | 3.28% |
March 31, 2019 | 2.24% |
December 31, 2018 | 2.93% |
September 30, 2018 | 3.41% |
June 30, 2018 | 3.78% |
March 31, 2018 | 3.52% |
Date | Value |
---|---|
December 31, 2017 | 3.82% |
September 30, 2017 | 1.99% |
June 30, 2017 | 4.25% |
March 31, 2017 | 1.70% |
December 31, 2016 | 2.83% |
September 30, 2016 | 3.99% |
June 30, 2016 | 5.58% |
March 31, 2016 | 3.58% |
December 31, 2015 | 3.82% |
September 30, 2015 | 3.69% |
June 30, 2015 | 4.95% |
March 31, 2015 | 3.57% |
December 31, 2014 | 3.10% |
September 30, 2014 | 3.56% |
June 30, 2014 | 3.49% |
March 31, 2014 | 1.76% |
December 31, 2013 | 1.66% |
September 30, 2013 | 1.15% |
June 30, 2013 | 2.62% |
March 31, 2013 | 1.03% |
December 31, 2012 | 0.10% |
September 30, 2012 | 2.49% |
June 30, 2012 | 3.73% |
March 31, 2012 | 1.57% |
December 31, 2011 | 0.69% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
1.00%
Minimum
Jun 2020
9.98%
Maximum
Sep 2019
3.26%
Average
2.92%
Median
Profit Margin (Quarterly) Benchmarks
Hypera SA | 21.47% |
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | -14.54K% |
IGC Pharma Inc | -2.74K% |
NovaBay Pharmaceuticals Inc | -122.2% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | 18.18% |
Return on Assets | 5.50% |
Return on Invested Capital | 12.34% |
Gross Profit Margin (Quarterly) | 29.22% |
Operating Margin (Quarterly) | 5.77% |
Return on Net Operating Assets | 5.82% |